1.Effects of different culture systems on the culture of prepuberal buffalo (Bubalus bubalis) spermatogonial stem cell-like cells in vitro
Ting Ting LI ; Shuang Shuang GENG ; Hui Yan XU ; Ao Lin LUO ; Peng Wei ZHAO ; Huan YANG ; Xing Wei LIANG ; Yang Qing LU ; Xiao Gan YANG ; Ke Huan LU
Journal of Veterinary Science 2020;21(1):13-
2.Equilibria between the K binding and cation vacancy conformations of potassium channels.
Yao HE ; Bo ZHANG ; Hao DONG ; Penglin XU ; Xiaoying CAI ; Ting ZHOU ; Mu YU ; Jun LIANG ; Xiao ZHENG ; Changlin TIAN
Protein & Cell 2019;10(7):533-537
3.Professor 's academic thoughts and acupoint selection experience for hot flashes.
Xiao-Liang WU ; Jian-Hua SUN ; Yan SHENG ; Meng-Qian YUAN ; Dan MIAO ; Ya-Fang SONG ; Tian-Cheng XU ; Wan-Li XU ; Ting-Ting ZHAO ; Yue YI ; Li-Jun BAI
Chinese Acupuncture & Moxibustion 2019;39(9):989-991
Professor is a well-known national veteran doctor with over 70 years of clinical experience. He has unique academic thoughts and clinical experience for common diseases and some difficult and complicated diseases. This paper mainly introduces professor 's syndrome-differentiation thought and experience of acupoint selection for hot flashes. It is emphasized that common hot flashes, such as hot flashes and night sweats, are different between and . While regulating and , more attention should be paid to - harmony, which is not only suitable for women's perimenopausal syndrome, but also for a series of clinical diseases caused by refractory drugs such as endocrine therapy after breast cancer surgery. At the same time of acupoint selection based on syndrome differentiation, a more rational prescriptions should be made according to the duration of the disease and the experience acupoints to improve the clinical efficacy.
Acupuncture Points
;
Acupuncture Therapy
;
Breast Neoplasms
;
surgery
;
Female
;
Hot Flashes
;
therapy
;
Humans
;
Syndrome
4.Patterns of Failure and Survival Trends in 3,808 Patients with Stage II Nasopharyngeal Carcinoma Diagnosed from 1990 to 2012: A Large-Scale Retrospective Cohort Study
Xue Song SUN ; Di Han LIU ; Sai Lan LIU ; Qiu Yan CHEN ; Shan Shan GUO ; Yue Feng WEN ; Li Ting LIU ; Hao Jun XIE ; Qing Nan TANG ; Yu Jing LIANG ; Xiao Yun LI ; Jin Jie YAN ; Ming Huang HONG ; Jun MA ; Lin Quan TANG ; Hai Qiang MAI
Cancer Research and Treatment 2019;51(4):1449-1463
PURPOSE: The purpose of this study was to investigate the survival trends and patterns of failure in patients with stage II nasopharyngeal carcinoma (NPC) treated with radiotherapy (RT) and chemotherapy over the last 20 years. MATERIALS AND METHODS: Thirty-eight hundred and eight patients diagnosed with stage II NPC between January 1990 and December 2012 were involved in this retrospective cohort study. All patients were treated with RT. According to the main imaging techniques and RT technology, we categorized these patients into four calendar periods: 1990-1996, 1997-2002, 2003-2007, and 2008-2012. Overall survival (OS), progression-free survival (PFS), locoregional relapse-free survival (LRFS), and distant metastasis–free survival (DMFS) were served as the clinical outcome. RESULTS: After a median follow-up period of 84.7 months, we observed increasing trends in survival and disease control. The 3- and 5-year OS rates increased from 87.1% and 78.7% in the first calendar period to 97.4% and 94.5% in the last calendar period, respectively (p<0.001). Additionally, significant increasing trends could be seen in the PFS and LRFS during the four calendar periods. In the subgroup analysis, the LRFS in patients older than 50 years at diagnosis showed greater improvement than younger patients. However, the rate of distant metastasis was stable and relatively low, as the 5-year DMFS ranged from 90.5% to 94.7% among the four calendar periods. CONCLUSION: The survival rates in patients with stage II NPC showed increasing trends from 1990 to 2012. The advance of RT provided excellent locoregional control and enhanced OS.
Cohort Studies
;
Diagnosis
;
Disease-Free Survival
;
Drug Therapy
;
Follow-Up Studies
;
Humans
;
Neoplasm Metastasis
;
Prognosis
;
Radiotherapy
;
Retrospective Studies
;
Survival Rate
5.Subdivision of Nasopharyngeal Carcinoma Patients with Bone-Only Metastasis at Diagnosis for Prediction of Survival and Treatment Guidance
Xue Song SUN ; Yu Jing LIANG ; Sai Lan LIU ; Qiu Yan CHEN ; Shan Shan GUO ; Yue Feng WEN ; Li Ting LIU ; Hao Jun XIE ; Qing Nan TANG ; Xiao Yun LI ; Jin Jie YAN ; Lin Quan TANG ; Hai Qiang MAI
Cancer Research and Treatment 2019;51(4):1259-1268
PURPOSE: The purpose of this study was to subdivide M1 stage nasopharyngeal carcinoma (NPC) patients with bone-only metastases for prognosis prediction while identifying the treatment effect of locoregional radiotherapy (LRRT) and metastasis radiotherapy (MRT) among patients with different risk. MATERIALS AND METHODS: From November 2006 to October 2016, a total of 226 patients with bone-only metastasic NPC were retrospectively enrolled. All patients developed distant lesions before receiving treatment. All potential prognostic factors were considered and the correlation of the M1 subdivisions with overall survival (OS) was determined by Cox regression hazards model. Kaplan–Meier curves were used to appraise survival condition and log-rank testing was used to compare the differences. RESULTS: The median follow-up time was 33.9 months (range, 3 to 126 months). According to multivariate Cox proportional hazard analysis, the number of metastatic lesions and Epstein-Barr virus (EBV) DNA status after palliative chemotherapy (PCT) were independent prognostic factors for OS. Thus, we subdivided patients into three risk groups according to these two factors. Systemic chemotherapy combined with LRRT may benefit patients in low- and intermediate-risk groups but not in the high-risk group. Further aggressive MRT based on systemic chemotherapy showed no survival benefit in any risk group. CONCLUSION: The stratification of NPC patients with bone-only metastasis based on EBV DNA after PCT and the number of metastatic lesions provided promising prognostic value and could aid clinicians in person-specific treatment.
Diagnosis
;
DNA
;
Drug Therapy
;
Follow-Up Studies
;
Herpesvirus 4, Human
;
Humans
;
Neoplasm Metastasis
;
Prognosis
;
Proportional Hazards Models
;
Radiotherapy
;
Retrospective Studies
6.Metabolomic Profiling Differences among Asthma, COPD, and Healthy Subjects: A LC-MS-based Metabolomic Analysis.
Ying LIANG ; Xiao Yan GAI ; Chun CHANG ; Xu ZHANG ; Juan WANG ; Ting Ting LI
Biomedical and Environmental Sciences 2019;32(9):659-672
OBJECTIVE:
Asthma and chronic obstructive pulmonary disease (COPD) feature different inflammatory and cellular profiles in the airways, indicating that the cellular metabolic pathways regulating these disorders are distinct.
METHODS:
We aimed to compare the serum metabolomic profiles among mild persistent asthmatic patients, individuals with stable COPD, and healthy subjects and to explore the potential metabolic biomarkers and pathways. The serum metabolomic profiles of 17 subjects with mild persistent asthma, 17 subjects with stable COPD, and 15 healthy subjects were determined by an untargeted metabolomic analysis utilizing liquid chromatography-mass spectrometry. A series of multivariate statistical analyses was subsequently used.
RESULTS:
Multivariate analysis indicated a distinct separation between the asthmatic patients and healthy controls in electrospray positive and negative ions modes, respectively. A total of 19 differential metabolites were identified. Similarly, a distinct separation between asthma and COPD subjects was detected in the two ions modes. A total of 16 differential metabolites were identified. Among the identified metabolites, the serum levels of hypoxanthine were markedly higher in asthmatic subjects compared with those in COPD or healthy subjects.
CONCLUSION
Patients with asthma present a unique serum metabolome, which can distinguish them from individuals with COPD and healthy subjects. Purine metabolism alteration may be distinct and involved in the pathogenesis of asthma.
7.Shensong Yangxin Capsules in the adjuvant treatment of stable angina pectoris:a Meta-analysis and trial sequential analysis.
Yuan-Tang XI ; Li-Yi YUAN ; Yuan-Yuan ZENG ; Man-Li YAN ; Xiao-Ru LIANG ; Ai-Ting FENG ; Wei WU
China Journal of Chinese Materia Medica 2019;44(17):3816-3824
To systemically evaluate the benefits and side effects of Shensong Yangxin Capsules( SYC) in the adjuvant treatment of stable angina pectoris( SAP). Chinese and English databases( PubMed,EMbase,the Cochrane Library,CBM,CNKI,VIP,Wan Fang database) were retrieved to collect the randomized controlled trials( RCTs) about therapeutic efficacy of SYC combined with routine drug( trial group) vs routine drug( control group) in the treatment of SAP. The methodological quality of the RCTs was evaluated based on the cochrane risk of bias assessment tool. The data were extracted and Meta-analyzed by Reviewer Manager 5. 3. TSA 0. 9 software was used for trial sequential analysis( TSA) of the total effective rate of symptoms improvement. A total of 15 RCTs with 1 316 participants were included. RESULTS:: of Meta-analysis showed that the total effective rate of angina symptoms improvement( RR = 1. 15,95% CI[1. 09,1. 21],P<0. 001) of trial group were significantly higher than those of control group,with statistical significance,the total effective rate of electrocardiograms( ECG) improvement( RR = 1. 10,95% CI[0. 94,1. 29],P = 0. 25) of trial group were significantly higher than those of control group,but the difference was not statistically significant. After treatment,the improvement of the total time of 24 h general ischemia( SMD =-1. 21,95%CI[-1. 97,-0. 45],P = 0. 002),the ST-segment depression amplitude( SMD =-1. 30,95%CI [-1. 52,-1. 09],P<0. 001),the duration of angina pectoris attack( SMD =-1. 16,95% CI[-1. 36,-0. 95],P< 0. 001),the angina pectoris attack every week( SMD =-0. 80,95%CI[-1. 10,-0. 50],P<0. 001),the onsumption of nitroglycerin every week( SMD=-0. 72,95%CI[-1. 05,-0. 39],P<0. 001) in the trial group were better than that of the control group,and the difference was statistically significant. Besides,the improvement of the blood lipid and high sensitivity C reactive protein( hs-CRP) in the trial group were better than those of the control group after treatment,and the difference was statistically significant( P< 0. 001). Funnel plots and Egger's linear regression showed that there was no publication bias. By sensitivity analysis,it showed that the results of this study were stable and reliable. No obvious adverse drug reactions were observed in all studies. TSA analysis showed that the evidence of Meta-analysis was reliable. SYC combined with routine Western medicine treatment for SAP can improve the total effective rate of angina pectoris,reduce 24 h total ischemia time,ST segment depression amplitude,duration of angina pectoris attack,frequency of angina pectoris attack and nitroglycerin dosage,and also can improve blood lipid and hs-CRP levels.
Adjuvants, Pharmaceutic
;
Angina, Stable
;
drug therapy
;
C-Reactive Protein
;
analysis
;
Capsules
;
Drugs, Chinese Herbal
;
therapeutic use
;
Electrocardiography
;
Humans
;
Lipids
;
blood
;
Randomized Controlled Trials as Topic
8.Comparative study on infection rate of different adeno-associated virus for knee joint cartilage in mice.
Jia-Ming HU ; Quan CHEN ; Jin-Yi ZHOU ; Jin-Ting WU ; Huan YU ; Fang-da FU ; Hong-Feng RUAN ; Lu-Wei XIAO ; Cheng-Liang WU ; Pei-Jian TONG
China Journal of Orthopaedics and Traumatology 2019;32(8):750-755
OBJECTIVE:
To explore infection rate of different adeno-associated virus (AAV) on knee joint cartilage in mice and to find a good gene editing tool for mice chondrocytes of knee joint.
METHODS:
Forty-five 4-week-old SPF C57BL/6 weighed(14.3±0.2) g were selected. According to different injections(6 μl) for right knee joint, mice were divided into 9 different groups, 5 mice in each group. The groups were such as following:control group (normal saline), Vigene 2 group (AAV2 from vigene biosciences, titer for 1×10¹³ vg/ml), Vigene 5 group (AAV5 from vigene biosciences, titer for 1×10¹³ vg/ml), Vigene 6 group (AAV6 from vigene biosciences, titer for 1×10¹³ vg/ml), Vigene 7 group (AAV7 from vigene biosciences, titer for 1×10¹³ vg/ml), Vigene 8 group (AAV8 from vigene biosciences, titer for 1×10¹³ vg/ml), Vigene 9 group (AAV9 from vigene biosciences, titer for 1×10¹³ vg/ml), Hanbio DJ group(AAV2-DJ from Hanbio, titer for 1×10¹² vg/ml), Hanbio 5 group (AAV5 from Hanbio, titer for 1×10¹² vg/ml). All AAVs were over-expressed green fluorescent protein(GFP). Knee joint specimens were taken and observed injury of cartilage under stereomicroscope at 30 days after injection, then 10 μm thick frozen sections were prepared. Distribution of green fluorescent protein of meniscus and cartilage of knee joint was observed under fluorescence microscope.
RESULTS:
Stereomicroscope observation indicated that no obvious lesion was observed in knee joint cartilage of mice after intra-articular injection of AAV. According to frozen sections of knee joints, strong green fluorescence was observed in knee joint cartilage in all AAV experimental groups. Compared with other groups, significantly stronger green fluorescence were observed both in AAV2 and AAV7 groups, whose average fluorescence density was 0.077±0.020 and 0.061±0.022. There were significant differences between two groups and other groups.
CONCLUSIONS
AAV could infect chondrocyte of knee joint in vivo by injecting into knee joint cavity. Higher infection efficiency of AAV2 and AAV7 on knee joint cartilage were observed. Local injection of AAV into knee joint cavity could be used as an effective tool for gene editing of knee joint chondrocyte.
Animals
;
Cartilage
;
Dependovirus
;
Green Fluorescent Proteins
;
Knee Joint
;
Mice
;
Mice, Inbred C57BL
9.Application status of 3D printing patient-specific instrumentation in total knee arthroplasty.
Liang FANG ; Rui DONG ; Hong-Ting JIN ; Pei-Jian TONG ; Lu-Wei XIAO
China Journal of Orthopaedics and Traumatology 2019;32(6):582-586
Recently, the joint replacement has gradually become a common operation of orthopedics. It's also the hot spot in current investigations. The increasing number of reports about the 3D printing technology such as patient-specific instrumentation(PSI) is applied to hip and knee replacement. It plays an important role in supporting operation especially for complex cases. However, it is still at the primary stage. This article reviews the relevant literature, analyzes and collates the research status of the application of 3D printing PSI in total knee arthroplasty, and summarizes its effectiveness in the application of knee arthroplasty from the aspects of individual preoperative planning, intraoperative operation and postoperative functional recovery, especially complex knee surgery such as obesity and knee deformity. The necessity of clinical application is discussed, and the existing problems and controversies in the current clinical application are summarized in order to provide references for the future research direction and clinical application.
Arthroplasty, Replacement, Knee
;
Humans
;
Knee Joint
;
Knee Prosthesis
;
Postoperative Period
;
Printing, Three-Dimensional
10.Value of S100A8 in evaluating the prognosis of children with acute lymphoblastic leukemia.
Mei-Fei OUYANG ; Dan WANG ; Ying-Ting LIU ; Lin-Yong XU ; Ming-Yi ZHAO ; Xiao-Cheng YIN ; Min XIE ; Liang-Chun YANG ; Ming-Hua YANG
Chinese Journal of Contemporary Pediatrics 2019;21(4):359-364
OBJECTIVE:
To study the association between S100A8 expression and prognosis in children with acute lymphoblastic leukemia (ALL).
METHODS:
The clinical data of 377 children with ALL who were treated with the CCLG-2008-ALL regimen were retrospectively reviewed. ELISA and PCR were used to measure serum protein levels and mRNA expression of S100A8. The Kaplan-Meier method was used for survival analysis and a Cox regression analysis was also performed.
RESULTS:
The children were followed up for 56 months, and the overall survival rate of the 377 children was 89.1%. The prednisone good response group had significantly lower S100A8 protein and mRNA levels than the prednisone poor response group (P<0.01). In the children with standard or median risk, both S100A8 protein and mRNA levels were associated with event-free survival rate (P<0.05). There were significant differences in S100A8 protein and mRNA levels between the children with different risk stratifications (P<0.01). The children who experienced events had significantly higher S100A8 protein and mRNA levels than those who did not (P<0.01). The Kaplan-Meier survival analysis and the Cox regression model suggested that S100A8 overexpression was an independent risk factor for the prognosis of children with ALL.
CONCLUSIONS
High S100A8 expression may be associated with the poor prognosis of children with ALL and is promising as a new marker for individualized precise treatment of children with ALL.
Calgranulin A
;
metabolism
;
Child
;
Disease-Free Survival
;
Humans
;
Precursor Cell Lymphoblastic Leukemia-Lymphoma
;
Prognosis
;
Retrospective Studies

Result Analysis
Print
Save
E-mail